Rubbiano – Parma, Italy | Sep 19, 2024: – Lincotek announced this week that it will be expanding its Medical Division Headquarters in Trento (Italy). The global solution provider for the orthopedic market anticipates that the 4,000 sq m facility will be operational in the second half of 2025, embodying the vision of a Medical Campus in the area. It will nearly double the company’s production footprint, laying out the infrastructure for sustained long-term growth.
Lincotek’s decision is driven by a desire to meet and exceed customers’ expectations, matching ever-increasing demand from a dynamic and evolving market. Investment in spaces, competencies and capabilities is critical in an environment where the bar for expectations is set at continuously higher levels.
The expanded HQ is set to be a center of industrial acceleration in the orthopedic sector, providing 360-degree support to customers – from initial idea to delivery. As a result, Lincotek will be able to continue to offer industry-leading time to market for cutting-edge medical devices.
“We’re fully focused on the development of solutions for the orthopedic sector at a time of increasing complexity and technological innovation,” said Andrea Colombo, Lincotek Group CEO. “The expansion of our facilities in Trento into a new hi-tech campus will help us meet the needs of customers into the future. It reflects our culture of continuous innovation and presents exciting new opportunities for everyone involved in our Medical Division.”
Fostering industry-academic collaboration and being able to rely on an inherent knowledge within the company, handed down year after year, Lincotek envisions the campus supporting a cross-fertilization of ideas and strengthening its role as a center for expertise and deep scientific and technological understanding. This will also allow the business to capitalize on trends towards automation, customization and optimization of the supply chain, while helping to reduce waste and contribute to a greener economy.
Gennaro D’Andrea, Global General Manager of the Medical Division, said: “This is an exciting and inspiring time for the business, as we gear up to face the future and keep up with evolving customer expectations. With the investments we already approved and expect to be operative from the second half of 2025, we will increase our production capacity by 40%, ensuring new products get to market even quicker than they do today. We always invest to grow together with our customers – they can plan for the future with certainty, knowing we’ll be right at their side to support their projects and bolster their success.”
About Lincotek
Lincotek is a global solution provider for services in niche markets including Industrial Gas Turbines, Aerospace and Medical Device applications, as well as a leading manufacturer of industrial coating equipment and oneof the most respected producers in the Additive Manufacturing field. The Group is family-owned and has more than 1,700 employees located in 20 production facilities across Europe, North America and Asia – lincotek.com.
Media Contact: Francesca Pedrotti, Head of Global Communication – Lincotek marketing@lincotek.com, +39 345 6203212
